Executive Team

The Arbor management team is composed of seasoned industry professionals who collectively have decades of experience and expertise in the pharmaceutical industry spanning a wide array of disciplines. Through its comprehensive network of industry partners and corporate leadership, Arbor is poised to rapidly introduce novel treatments that will enhance the treatment and management of diseases in carefully selected specialty areas.


Brian Adams, PhD, MBA

Vice President, Business Development

Dr. Adams has a career of over 15 years in the life sciences in both academia and industry. Prior to joining Arbor, he served as Head of Business Development at Cornerstone Therapeutics and Senior Director of Business Development at Shionogi Pharma (formerly Sciele Pharma). Brian originally started with Shionogi as the Intellectual Property Manager and was responsible for handling the company’s patents and trademarks. Before working for Shionogi, he served as a patent agent and scientific advisor at Pabst Patent Group LLP and Holland & Knight, LLP in the areas of biotechnology and chemistry. He has been very active in the Southeast life sciences community and is a member of the SE BIO Board of Directors. Brian has earned a B.S. in Biology from Wake Forest University, a PhD in Molecular and Systems Pharmacology from Emory University, and an MBA from the University of Georgia.


Steven Caras, MD, PhD

Vice President, Clinical Development

Dr. Steven Caras is a gastroenterologist and biomedical engineer. He has a Bachelors degree in Chemical Engineering from Arizona State University and Masters and Ph.D. degrees in Bioengineering from the University of Utah in Salt Lake City. Steve obtained his medical degree from the University of Miami. He did his residency training in internal medicine at Washington University in St. Louis and his gastroenterology fellowship at University of Virginia in Charlottesville. After his gastroenterology fellowship, Steve worked as a medical reviewer in the Cardio-Renal Division of FDA, where he was mainly involved in antihypertensive and antiarrhythmic drugs. Dr. Caras has over 16 years of experience in all aspects of Phase I-Phase IV clinical development and medical affairs and has worked for Solvay Pharmaceuticals and for PAREXEL, a large CRO. Steve currently volunteers for a local chamber of commerce which evaluates pharmaceutical and medical device companies and provides these companies with essential development, regulatory, and business feedback. He also serves on the Kennesaw State University Advisory Board for the College of Science and Mathematics.


Mary Lou Freathy, JD

Vice President, Regulatory Affairs, Quality, & Manufacturing

Mary Lou has more than 30 years of pharmaceutical experience in quality, regulatory affairs, and compliance including over 15 years supporting the growth and compliance of life science companies. Mary Lou was previously Senior Vice President of Quality, Regulatory Affairs, and Chief Compliance Officer of G&W Laboratories. Prior to that, she held several executive managerial positions at Paddock Laboratories, Pliva, Inc., and Dey Laboratories where she started her pharmaceutical career. Mary Lou belongs to several professional societies including RAPS, PDA, ISPE, and ASQ. She holds a J.D. from the Empire School of Law, and a B.A. in Chemistry from the State University of New York. She is also a Certified Compliance Professional.

Kevin2 (1)

Kevin Guthrie

Vice President, Commercial Operations

Kevin Guthrie brings 33 years of experience in the Healthcare Industry, most recently serving as President of HealthLink Dimensions.  During his time with HealthLink Dimensions, Kevin has guided the company to record client and revenue growth, resulting in recognition as one of America’s fastest-growing private companies for five consecutive years.  Previously he served in roles as Vice President of Marketing, Sales, and Operations for Solvay Pharmaceuticals, with US sales of $1.5B. He has also held Sales, Marketing, and Operational leadership roles within Bristol-Myers Squibb. During his time with Solvay and BMS, Kevin worked in numerous therapeutic areas including neuroscience, cardiovascular, anti-infectives, psychiatry, GI, endocrinology and women’s health.  Kevin completed his B.S. in Business Administration at Murray State University and has completed the INSEAD International Executive Study Program in France and Singapore.


Jason McCarthy

Chief Financial Officer

Jason brings to Arbor over 20 years of progressive accounting, auditing and finance experience from a mixture of public and private companies. Prior to Arbor, Jason managed the accounting function and was responsible for all SEC filings at Lodgian, Inc., an owner and operator of franchised hotels. Jason also successfully founded his own company specializing in Sarbanes-Oxley implementations and internal control consulting for some of the top public companies in Atlanta. In addition, Jason also worked for PwC in their audit function specializing in real estate and manufacturing. Jason is a Certified Public Accountant in the state of Georgia and a graduate of Ohio University with dual bachelor’s degrees in Accounting and Management Information Systems.


Thom Rowland

President and Chief Operating Officer

Thom Rowland is an industry veteran who started his career as a sales representative for UCB Pharmaceuticals. Thom later held various marketing positions with UCB prior to taking the position of head of marketing for Scandipharm. He played a lead role in turning the Scandipharm business around prior to its sale to Axcan Pharmaceuticals. Thom then served as a Vice President of Sales and Marketing for several business units at Solvay Pharmaceuticals where he was again instrumental in turning around an underperforming area. Thom was one of the founders of Ventrus Biosciences which completed a successful IPO in 2010.


Ed Schutter

Chief Executive Officer

Ed Schutter has over thirty years of pharmaceutical industry experience and was previously President of Sciele (Shionogi) Pharmaceuticals prior to joining Arbor. Prior to Sciele, Ed served as VP of Global Business development at Solvay Pharmaceuticals based in Basel, Switzerland. He also held several senior management roles at the U.S. subsidiary of Solvay during his twenty years with the organization. He began his pharmaceutical career with Reid-Provident Labs, a small entrepreneurial pharmaceutical company based in Atlanta, GA. Ed is a registered pharmacist with a degree in Pharmaceutical Sciences from Mercer University and an MBA from Kennesaw State University. He is currently a board member of Vitruvias Therapeutics, Vensun Pharmaceuticals, Establishment Labs, and Mercer University.